• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[前列腺乳头状腺癌对抗雄激素治疗反应良好且放疗延迟:一例报告]

[Papillary adenocarcinoma of the prostate with good response to antiandrogen therapy and delayed radiotherapy: a case report].

作者信息

Ishizu K, Konishi M, Joko K, Takihara H, Sakatoku J, Tanaka K

机构信息

Department of Urology, Nagato General Hospital.

出版信息

Hinyokika Kiyo. 1992 Mar;38(3):343-6.

PMID:1381864
Abstract

A 76-year-old man complained of initial hematuria and dysuria. Right lobe of the prostate was elastic soft, enlarged and hypoechoic. The serum levels of PA and gamma-Sm were abnormally high. Prostatic biopsy showed papillary adenocarcinoma which was stained by prostatic specific antigen (PA). The cancer was clinically diagnosed as stage C. Antiandrogen therapy was performed. After three months, the prostatic tumor markers decreased to the normal range and the tumor reduced in size without any findings of metastasis on CT scan. Because prostatic biopsy showed viable cancer cells, radiotherapy was added. After six months, the tumor reduced in size without any signs of metastasis on CT scan and prostatic biopsy revealed no viable cancer cells or elevation of the tumor markers. The positive staining for PA and the good response to antiandrogen therapy in our case support the view that papillary adenocarcinoma of the prostate is only a morphologic variant of ordinary prostatic carcinoma (acinous adenocarcinoma).

摘要

一名76岁男性主诉初始血尿和排尿困难。前列腺右叶质地弹性柔软,增大且呈低回声。血清PA和γ-Sm水平异常升高。前列腺活检显示为乳头状腺癌,经前列腺特异性抗原(PA)染色。该癌症临床诊断为C期。进行了抗雄激素治疗。三个月后,前列腺肿瘤标志物降至正常范围,肿瘤体积缩小,CT扫描未发现转移迹象。由于前列腺活检显示有存活的癌细胞,因此增加了放疗。六个月后,肿瘤体积缩小,CT扫描未发现转移迹象,前列腺活检未发现存活的癌细胞,肿瘤标志物也未升高。我们病例中PA的阳性染色以及对抗雄激素治疗的良好反应支持了前列腺乳头状腺癌只是普通前列腺癌(腺泡腺癌)的一种形态学变体这一观点。

相似文献

1
[Papillary adenocarcinoma of the prostate with good response to antiandrogen therapy and delayed radiotherapy: a case report].[前列腺乳头状腺癌对抗雄激素治疗反应良好且放疗延迟:一例报告]
Hinyokika Kiyo. 1992 Mar;38(3):343-6.
2
[Mucinous adenocarcinoma of the prostate with good response to hormonal therapy: a case report].[对激素治疗反应良好的前列腺黏液腺癌:一例报告]
Hinyokika Kiyo. 1991 Sep;37(9):1057-60.
3
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.评估调强放疗联合原位基因治疗加或不加激素治疗前列腺癌的I-II期试验——前列腺特异抗原反应及活检数据中期报告
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1520-9. doi: 10.1016/j.ijrobp.2003.09.083.
4
[Signet ring cell carcinoma of the prostate successfully treated with endocrine therapy: a case report].[前列腺印戒细胞癌经内分泌治疗成功治愈:一例报告]
Hinyokika Kiyo. 2003 May;49(5):281-3.
5
[Small cell carcinoma of the prostate successfully treated with combined chemotherapy and radiotherapy: a case report].[前列腺小细胞癌经化疗和放疗联合治疗成功:一例报告]
Hinyokika Kiyo. 2002 Feb;48(2):97-100.
6
[Giant prostate carcinoma treated effectively with endocrine therapy: case report].[内分泌治疗有效治疗巨大前列腺癌:病例报告]
Hinyokika Kiyo. 2007 Feb;53(2):133-5.
7
[A case of prostate cancer with multiple pulmonary metastases].[一例伴有多发肺转移的前列腺癌病例]
Hinyokika Kiyo. 1987 Mar;33(3):441-6.
8
[Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].[前列腺小细胞癌/腺癌合并:2例报告]
Hinyokika Kiyo. 2007 Jul;53(7):489-92.
9
[Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy].醋酸氯地孕酮作为联合雄激素阻断治疗后前列腺癌复发的替代抗雄激素治疗的临床效用
Hinyokika Kiyo. 2009 Apr;55(4):199-203.
10
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.临床局限性前列腺癌患者在根治性前列腺切除术前行8个月新辅助雄激素剥夺治疗的生化和病理效应
J Urol. 1996 Jan;155(1):213-9.